Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reducing side effects of immunotherapy using genetically modified hematopoietic cells

Reducing side effects of immunotherapy using genetically modified hematopoietic cells

US Patent 12318446 · Granted Jun 3, 2025

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Method for manufacturing a patient specific cell population using a multifunctio2025
Compositions and methods for treating cancer with DuoCARs2025
Adapter-based retroviral vector system for the selective transduction of target 2025
Sterile connector2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025
Immunotherapy of cancer patients using CAR T or CAR NK cells combined with hemat2025
Regulatory T cell expressing a chimeric antigen receptor2024
Reagents for detection of chimeric antigen receptor cells2024
CD62L specific lentiviral vector particle for targeted transduction of T cell su2024